From: Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation
Cell lines
IC50(μM)
Prostate
LN-CAP
15.2
DU-145
19.2
Pancreas
BX-PC3
19.8
PANC-1
31.6
Renal
SN12C
23.6
RXF393
19.9
769P
34.6
Glioblastoma
LN229
18.2
U373MG
U87MG
30.8
Breast
CG-5
MDA-MB 231
33.6
MDA-MB 468
41.2
MDA-MB 436
40.1